Cellestia Biotech competitorsClear all
Cellestia Biotech's top competitors include Heron Therapeutics, Bellerophon Therapeutics, UNITY Biotechnology and Synthorx.
| Save Comparison |  Cellestia Biotech Cellestia Biotech is a biopharmaceutical company with strategic focus on anti-cancer drugs modulating the NOTCH signaling pathway. |  Heron Therapeutics Heron Therapeutics is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery platform. |  Bellerophon Therapeutics Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. |  Synthorx Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics. | |
Founding Date | Founding Date 2014 | Founding Date 1983 | Founding Date 2009 | Founding Date 2009 | Founding Date 2014 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Basel, CH HQ Epalinges, CH | Locations San Diego, US HQ Jersey City, US | Locations Warren, US HQ | Locations South San Francisco, US HQ Brisbane, US | Locations San Diego, US HQ |
Employees | Employees 6 | Employees 23117% increase | Employees 1715% decrease | Employees 7 | Employees 3939% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.6 b | Valuation ($) 71.8 m | Valuation ($) 366.2 m | Valuation ($) 2.2 b |
Twitter followers | Twitter followers 144 | Twitter followers N/A | Twitter followers N/A | Twitter followers 3.2 k | Twitter followers 840 |
Alexa Website Rank | Alexa Website Rank 374283 | Alexa Website Rank 354402 | Alexa Website Rank 264284 | Alexa Website Rank 251103 | Alexa Website Rank 443374 |
Employee Rating | Employee Rating N/A | Employee Rating N/A | Employee Rating 1 | Employee Rating 3.4 | Employee Rating N/A |
Financial | |||||
Net income | Net income N/A | Net income ($204.7m) (FY, 2019) | Net income ($13.3m) (FY, 2019) | Net income ($82.2m) (FY, 2019) | Net income ($5.9m) (FY, 2017) |
Funding | |||||
Total funding raised | Total funding raised $ 48.6m | Total funding raised N/A | Total funding raised $ 80m | Total funding raised $ 210.6m | Total funding raised $ 79m |
For sources of this data, please see the company profile
View company profiles
Heron Therapeutics
HQ
San Diego, US
Employees
231↑ 17% increase
Heron Therapeutics is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery platform.
View companyBellerophon Therapeutics
HQ
Warren, US
Employees
17↓ 15% decrease
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases.
View company
UNITY Biotechnology
HQ
South San Francisco, US
Employees
7
Unity Biotechnology designs therapeutics that prevent various diseases of aging.
View companySynthorx
HQ
San Diego, US
Employees
39↑ 39% increase
Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics.
View company